These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 25701308)
1. Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category? Kim JW; Oh MM; Bae JH; Kang SH; Park HS; Moon du G J Infect Chemother; 2015 Jun; 21(6):434-7. PubMed ID: 25701308 [TBL] [Abstract][Full Text] [Related]
2. Comparison of antibiotic susceptibility of Escherichia coli between community-acquired and post-prostate biopsy acute bacterial prostatitis. Park MG; Cho MC; Cho SY; Lee JW Arch Esp Urol; 2019 Dec; 72(10):1018-1025. PubMed ID: 31823850 [TBL] [Abstract][Full Text] [Related]
3. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043 [TBL] [Abstract][Full Text] [Related]
4. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy. Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546 [TBL] [Abstract][Full Text] [Related]
5. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy. Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894 [TBL] [Abstract][Full Text] [Related]
6. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis. Oh MM; Chae JY; Kim JW; Kim JW; Yoon CY; Park MG; Moon du G Urology; 2013 Jun; 81(6):1209-12. PubMed ID: 23601450 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study. Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193 [TBL] [Abstract][Full Text] [Related]
9. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study. Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113 [TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment. Ekici S; Cengiz M; Turan G; Alış EE Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465 [TBL] [Abstract][Full Text] [Related]
11. Microbiological and clinical characteristics in acute bacterial prostatitis according to lower urinary tract manipulation procedure. Kim SH; Ha US; Yoon BI; Kim SW; Sohn DW; Kim HW; Cho SY; Cho YH J Infect Chemother; 2014 Jan; 20(1):38-42. PubMed ID: 24462423 [TBL] [Abstract][Full Text] [Related]
13. Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis. Park MG; Cho MC; Cho SY; Lee JW Urol Int; 2016; 96(4):443-8. PubMed ID: 26943143 [TBL] [Abstract][Full Text] [Related]
14. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Mosharafa AA; Torky MH; El Said WM; Meshref A Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225 [TBL] [Abstract][Full Text] [Related]
15. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. Millán-Rodríguez F; Palou J; Bujons-Tur A; Musquera-Felip M; Sevilla-Cecilia C; Serrallach-Orejas M; Baez-Angles C; Villavicencio-Mavrich H World J Urol; 2006 Feb; 24(1):45-50. PubMed ID: 16437219 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Lee YS; Han CH; Kang SH; Lee SJ; Kim SW; Shin OR; Sim YC; Lee SJ; Cho YH Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727 [TBL] [Abstract][Full Text] [Related]
17. [Microbiología, sensibilidad antibiótica y factores asociados a bacteriemia en la prostatitis aguda]. Ferré C; Llopis F; Jacob J Rev Esp Quimioter; 2016 Aug; 29(4):190-4. PubMed ID: 27305509 [TBL] [Abstract][Full Text] [Related]
18. Acute bacterial prostatitis in humans: current microbiological spectrum, sensitivity to antibiotics and clinical findings. Nagy V; Kubej D Urol Int; 2012; 89(4):445-50. PubMed ID: 23095643 [TBL] [Abstract][Full Text] [Related]
20. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Ha US; Kim ME; Kim CS; Shim BS; Han CH; Lee SD; Cho YH Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S96-101. PubMed ID: 18065208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]